What is ELAPRASE ® (Idursulfase)? ELAPRASE is a prescription medicine for patients with Hunter syndrome. ELAPRASE has been shown to improve walking ability in patients 5 yrs and older.

Learn more about how ELAPRASE® is administered and recommended dosage for MPS II treatment. Important: See Boxed Warning for life-threatening anaphylactic reactions. The information in this site is intended for U.S. healthcare professionals only.

2025年1月1日 · Elaprase is an IV infusion used to treat some of the symptoms of a genetic condition called Hunter's syndrome, also called mucopolysaccharidosis (MYOO-koe-pol-ee-SAK-a-rye-DOE-sis). Idursulfase contains a natural enzyme that some people lack because of a genetic disorder.

ELAPRASE ® (idursulfase) is a prescription medicine for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II), which was approved by the Food and Drug Administration (FDA) in 2006. The active substance in ELAPRASE is an enzyme that breaks down glycosaminoglycans (GAG).

ELAPRASE is a hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme indicated for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II). ELAPRASE has been shown to improve...

2025年3月9日 · ELAPRASE is a hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme indicated for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II). ELAPRASE has been shown to improve walking capacity in patients 5 years and older.

Idursulfase (brand name Elaprase), manufactured by Takeda, is a drug used to treat Hunter syndrome (also called MPS-II). [2] It is a purified form of iduronate-2-sulfatase , a lysosomal enzyme, and is produced by recombinant DNA technology in a human cell line.

Whether you've just been diagnosed or have been on treatment for a while, our goal is to help you get the answers and information you specifically need—and help make your treatment journey …

Elaprase is used to treat patients with Hunter syndrome. It is designed for long-term use. Hunter syndrome, which is also known as mucopolysaccharidosis II, is a rare, inherited disease that primarily affects male patients.

ELAPRASE is a formulation of idursulfase, a purified form of human iduronate-2-sulfatase, a lysosomal enzyme. Idursulfase is produced by recombinant DNA technology in a human cell